A detailed history of Jones Financial Companies Lllp transactions in Vericel Corp stock. As of the latest transaction made, Jones Financial Companies Lllp holds 541 shares of VCEL stock, worth $21,564. This represents 0.0% of its overall portfolio holdings.

Number of Shares
541
Previous 264 104.92%
Holding current value
$21,564
Previous $11,000 54.55%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$29.84 - $41.74 $8,265 - $11,561
277 Added 104.92%
541 $17,000
Q2 2025

Aug 13, 2025

BUY
$37.92 - $45.7 $1,971 - $2,376
52 Added 24.53%
264 $11,000
Q1 2025

May 28, 2025

BUY
$44.5 - $61.8 $4,183 - $5,809
94 Added 79.66%
212 $9,000
Q1 2025

May 16, 2025

BUY
$44.5 - $61.8 $2,892 - $4,017
65 Added 122.64%
118 $5,000
Q4 2024

Feb 05, 2025

BUY
$40.05 - $59.11 $2,122 - $3,132
53 New
53 $2,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $1.88B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.